-
Signature
-
/s/ Vanina de Verneuil
-
Issuer symbol
-
VIR
-
Transactions as of
-
05 Nov 2025
-
Net transactions value
-
-$12,307
-
Form type
-
4
-
Filing time
-
07 Nov 2025, 15:27:52 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| de Verneuil Vanina |
EVP, General Counsel, Corp Sec |
C/O VIR BIOTECHNOLOGY, INC., 1800 OWENS STREET, SUITE 900, SAN FRANCISCO |
/s/ Vanina de Verneuil |
07 Nov 2025 |
0002036234 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
VIR |
Common Stock |
Sale |
$12,307 |
-2,385 |
-3% |
$5.16 |
78,210 |
05 Nov 2025 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: